Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1451 (LINC01451) is a human long non-coding RNA (lncRNA) gene located on chromosome 9 (9q34), also previously known as HCCAT4 (hepatocellular carcinoma associated transcript 4)[1][14][16]. As a member of the LINC RNA family, LINC01451 does not encode a protein but is believed to play regulatory roles in gene expression, chromatin structure, and epigenetic modification, as is typical for this class of molecules[7][15]. LINC01451 has been associated in the literature with hepatocellular carcinoma and is considered a putative biomarker for this cancer type, but is not itself a validated therapeutic target, enzyme, receptor, or druggable molecule[10][7][15]. There are no known drugs directly targeting LINC01451 as of the current literature, nor established mechanisms of action or safety concerns for targeting this RNA specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1451 (LINC01451).